If you're looking to uncover family history or learn more about your health, here's how to decide which DNA testing kit is best for you.

Texans curious about their ancestry likely paid for a DNA test through 23andMe. But with their future unclear, what will happen to customers' data?

23andMe ended the quarter with cash and cash equivalents of $127 million, compared with $216 million as of March 31, 2024. Last month, 23andMe completed a 1-for-20 reverse stock split.

23andMe has shared preliminary support of the settlement, which is set to be heard by a judge for approval next month. In a statement, a spokesperson said that the company looked forward to ...

23andMe continues to operate as a part of TTAM According to a press release from 23andMe, TTAM acquired the company’s Personal Genome Service and its research operations.

23andMe says on its website that any buyer must comply with laws around handling customer data. The company plans to continue selling kits and offering subscriptions.

An update from 23andMe Holding ( ($MEHCQ) ) is now available. Chrome Holding Co. and its subsidiaries, collectively known as the Debtors, filed ...

23andMe, a genetic testing and biotech company, first announced in Oct. 2023 that the site had been the victim of a “credential stuffing attack,” during which hackers were able to use login ...

Kelly Krechmer was born in 1971, and claims in papers filed in New York County Surrogate Court she’s entitled to some of the ...

Regeneron intends for 23andMe to continue its consumer genome services without interruption. The transaction, pending bankruptcy court and regulatory approvals, is expected to close in the third ...

23andMe, Anne Wojcicki, and New Mountain Capital declined to comment. Board experts say the bid will likely attract scrutiny from investors, and raises red flags about what happens when a founder ...

23andMe has a new health initiative—here’s what you should know about what information the brand will collect, and why they’ve been in the news lately.